The link between lipedema and hormones should not be reduced to a single sentence. Saying “estrogen causes lipedema” is too simple; saying hormones are irrelevant is also inaccurate. Lipedema is a chronic condition that mainly affects women and is characterized by symmetrical subcutaneous fat enlargement, pain, tenderness, easy bruising and relative sparing of the feet; current guidance frames it as a multifactorial disorder involving tissue biology, genetic susceptibility, vascular-lymphatic factors and hormonal timing (Faerber et al., 2024; Herbst et al., 2021; Cifarelli et al., 2025).
This article focuses on why lipedema often becomes visible around puberty, pregnancy, postpartum changes and menopause. The broader causes are discussed in what causes lipedema, but here the main question is more specific: how can the same body react so strongly to hormonal transitions when routine blood tests may look normal?
The key idea is tissue response, not only hormone level
Puberty brings cyclical estrogen and progesterone activity, pregnancy greatly increases both, while menopause lowers systemic estrogen. Yet all three stages may trigger or worsen lipedema. This apparent paradox suggests that rapid hormonal fluctuation, receptor sensitivity, local hormone metabolism inside adipose tissue, inflammation and insulin sensitivity may matter more than a single blood level.
A 2026 systematic review grouped hormone-related hypotheses into general hormonal imbalance, possible growth hormone axis changes, metabolic signals involving adipokines, leptin and PPARγ, and changes in estrogen metabolism or estrogen receptor function (Lüchinger et al., 2026). Tomada (2025) similarly describes puberty, pregnancy and menopause as clinically important turning points. In practice, the question is not simply “is estrogen high or low?” but “how does this patient’s adipose and connective tissue respond to hormonal change?”
Estrogen receptors: ERα, ERβ and GPER
Estrogen does not work through one simple switch. ERα and ERβ are nuclear estrogen receptors that can influence gene expression, while GPER is a membrane-associated receptor involved in faster signaling. Their balance may shape how adipocytes, adipose stem cells, blood vessels and connective tissue respond to the same hormone environment.
Katzer et al. (2021) reviewed how estrogen signaling can affect adipogenesis, lipolysis, GLUT4, lipoprotein lipase, vascular growth and lower-body fat distribution. Al-Ghadban et al. (2024) showed that lipedema-derived adipose stem cells and adipocytes may differ from healthy controls in ERβ, ERα, GPER and estrogen-metabolizing gene responses. These findings are not diagnostic tests, but they help explain why a normal hormone blood test does not exclude tissue-level dysregulation.
Why puberty can be the first turning point
During puberty, female fat distribution shifts toward a more gynoid pattern, especially the hips, buttocks and thighs. In a person with lipedema susceptibility, these lower-body subcutaneous depots may respond more strongly to reproductive hormone cycling. The patient may describe it as “my upper body stayed normal, but my legs changed suddenly.” When symmetrical enlargement, touch pain, easy bruising and foot sparing appear together, lipedema symptoms helps organize the pattern clinically.
Pregnancy, postpartum and lactation
Pregnancy increases estrogen and progesterone, reduces insulin sensitivity later in pregnancy and raises prolactin during pregnancy and lactation. These changes can increase fat storage, fluid load and lipolysis resistance in susceptible tissue (Tomada, 2025). This is why worsening during pregnancy is not just a matter of “weight gain.” Movement reduction, venous dilation, sleep disruption, fluid shifts and postpartum recovery also interact with the tissue.
Why menopause may worsen symptoms even when estrogen falls
Menopause is confusing because systemic estrogen falls, yet some patients notice more pain, firmness, volume change and mobility limitation. One explanation is that the body is not responding only to absolute estrogen level. Receptor balance, local steroid metabolism inside adipose tissue, mitochondrial function, insulin sensitivity and inflammatory tone may change at the same time (Tomada, 2025; Lüchinger et al., 2026). This does not mean hormone therapy automatically treats lipedema; decisions about menopausal hormone therapy or contraception must consider vascular, metabolic and gynecologic risks.
Insulin, leptin, cortisol and adipose-tissue signals
Insulin is not the single cause of lipedema, but insulin resistance can worsen hunger, cravings, abdominal fat gain, fluid perception and difficulty mobilizing fat. Leptin and other adipokines are signals released by adipose tissue; PPARγ helps regulate adipocyte differentiation and fat-storage programs. Rabiee (2025) describes lipedema adipose tissue as a living microenvironment involving adipocytes, fibrosis, immune cells and inflammation rather than a passive fat store.
Cortisol should also be handled carefully. Stress does not cause lipedema by itself, but chronic pain, poor sleep and body-image pressure can affect appetite, glucose regulation and pain perception. Nutrition and exercise therefore work best when they are not presented as blame. lipedema nutrition helps calm the insulin and inflammation side of the plan, while lipedema exercises supports the muscle pump without punishing the patient.
Thyroid, prolactin, growth hormone and male cases
Thyroid disease is not a classic cause of lipedema, but hypothyroidism can add fatigue, constipation, weight gain and edema-like symptoms. Prolactin and growth hormone balance are discussed in the literature, but they are not established routine treatment targets (Lüchinger et al., 2026). Lipedema in men is rare; reported male cases have often been linked with endocrine or liver conditions that alter estrogen-testosterone balance (Cifarelli et al., 2025).
Do hormone tests diagnose lipedema?
No single hormone test diagnoses lipedema. Estradiol, progesterone, FSH, LH, prolactin, thyroid hormones, insulin or cortisol may help evaluate the patient’s general health, but lipedema remains a clinical diagnosis based on history, distribution, pain, bruising, foot sparing, weight-loss response and differential diagnosis. how lipedema is diagnosed places hormone history inside the full diagnostic process.
If symptoms began around puberty, pregnancy, postpartum change or menopause, that timing is worth mentioning at the visit. lipedema self-test can help patients organize these patterns before seeing a physician; it does not diagnose lipedema.
Conclusion
Hormones may open the door, but they are not the whole story. The most realistic model is a combination of hormonal fluctuation, estrogen receptor balance, local adipose-tissue hormone metabolism, insulin sensitivity, adipokines, inflammation, connective tissue and lymphatic load. This approach avoids blaming the patient and also avoids false promises: hormone-targeted treatment should never be started, stopped or changed for lipedema without individualized medical review.
